Helix Bio · Phase 2 Oncology Team Build
Phase 2 Oncology PI Consultant
interviewingLead protocol design + interim analysis for Phase 2 melanoma trial. 6mo, 8 hrs/mo.
Applicants
24
Shortlisted
6
Interviewing
2
Avg time to first response
31 hrs
Apply deadline
May 30, 2026
hourlyApplicant pipeline
8 total
Click any card to open the applicant detail drawer · drag-drop between columns lands in Phase 1 · current stage moves are persisted via the Move button in the drawer.
New
2Dr. Olu Adeyemi
Translational scientist · Wash U
Tier 2fit 76
Translational oncologyBiomarkers
via appliedapplied today
Dr. Rachel Goldberg
Adaptive design specialist · NYU
Tier 2fit 84
Adaptive Phase 2Bayesian methods
via Matchmakerapplied today
Shortlisted
2Dr. Marcus Lin
VP CMC · ex-Genentech · advisory
Tier 3fit 89
CMC strategyBLA prep
Active advisory at competitor (Acme Therapeutics)
via Matchmaker3 days ago — moved to shortlist
Dr. Anika Patel
CMC consultant · ex-Moderna · 12 yrs CDMO
Tier 2fit 81
mRNA CDMOProcess scale-up
via Matchmaker2 days ago — recruiter messaged
Interviewing
2Dr. Jane Smith
Principal Scientist · CDMO formulations · Cambridge MA
Tier 2fit 92
Phase 2 oncologyCMC strategy
via appliedyesterday — interview scheduled
Dr. Hiroshi Tanaka
Regulatory CMC · ex-Takeda · Tokyo
Tier 3fit 88
FDA AdComm prepICH Q12
via Scouttoday — panel scheduled Fri
Offer
1Dr. Maya Sen
Phase 2 PI · Mayo Clinic
Tier 3fit 95
Phase 2 oncologyPI experience
via appliedtoday — offer sent